DRREDDY's weekly performance was disappointing, with a return of -2.17%, underperforming its peers HINDUNILVR and DIVISLAB. The stock's high volatility of 30.89% contributed to its poor performance, making it a risky investment this week. In contrast, SUNPHARMA outperformed the pack with a return of 2.4%. DRREDDY's Sharpe Ratio of -0.27 and Max Drawdown of -3.75% further highlight its unattractive risk-return profile.

[Volatility: 30.89%]